D
Deborah J. Cook
Researcher at McMaster University
Publications - 942
Citations - 165225
Deborah J. Cook is an academic researcher from McMaster University. The author has contributed to research in topics: Intensive care & Randomized controlled trial. The author has an hindex of 173, co-authored 907 publications receiving 148928 citations. Previous affiliations of Deborah J. Cook include McMaster University Medical Centre & Queen's University.
Papers
More filters
Journal Article
Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials
Ryan Zarychanski,Alexis F. Turgeon,Dean Fergusson,Deborah J. Cook,Paul C. Hébert,Sean M. Bagshaw,Danny Monsour,Lauralyn McIntyre +7 more
TL;DR: The use of HES for acute volume resuscitation of critically ill patients, and in particular those with severe sepsis and septic shock, appeared to be associated with increased use of renal replacement therapy.
Journal ArticleDOI
Understanding and changing attitudes toward withdrawal and withholding of life support in the intensive care unit
TL;DR: To better understand attitudes about end-of-life care in general and withdrawal of life support in particular, four different sources of data were reviewed: 1) decision support tools, 2) qualitative research, 3) surveys, and 4) observational studies.
Journal ArticleDOI
Stress Ulcer Prophylaxis
TL;DR: This clinically focused article will review current controversies related to stress ulcer prophylaxis for critically ill adult patients, including bleeding frequency, risk factors, comparative efficacy, adverse effect profile, and overall cost-effectiveness of the available stress ulcers prophYLaxis regimens.
Journal ArticleDOI
Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients.
TL;DR: An assessment of the incidence and prevalence of venous thromboembolic outcome of interest, which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), in medicalsurgical intensive care unit (ICU) patients is based on 3 premises.
Journal ArticleDOI
Heparin-Induced Thrombocytopenia in Medical Surgical Critical Illness
Theodore E. Warkentin,Jo-Ann I. Sheppard,Diane Heels-Ansdell,John C. Marshall,Lauralyn McIntyre,Marcelo G. Rocha,Sangeeta Mehta,Andrew Davies,Andrew D. Bersten,Tim M. Crozier,David Ernest,Nicholas E. Vlahakis,Richard I. Hall,Gordon Wood,Germain Poirier,Mark Crowther,Deborah J. Cook +16 more
TL;DR: The lower risk of HIT in patients in the ICU receiving dalteparin appears related to both decreased antibody formation and decreased clinical breakthrough of HIT among patients forming antibodies.